Champions Oncology, Inc. (CSBR) dividend history

CSBRNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends April 30

Financials through Q1 FY2027, quarter ended Jul 31, 2026Last filing: 10-Q on Sep 11, 2026Score 9/30246% above fair value

$4.71+0.05 (+1.18%)

Close on Nov 13, 2026Market cap $65.49MP/E –Yield –

Dividends

No dividend per share appears in Champions Oncology's annual filings since fiscal 2011.

Parsed from the XBRL in Champions Oncology's annual and quarterly filings with the SEC
Per-share figures adjusted for the 1-for-12 reverse split on Aug 12, 2015
Fourth quarters derived from the annual report minus nine months
Every figure in the statements links to its source filing

Trailing twelve months. Peers are matched on business description, industry and size. Ticks are peers, the dot is CSBR.

Revenue growth6.7% · median -55.6%

Operating margin-1.7% · median -265.0%

Net margin-1.8% · median -344.2%

Advertisement
300 × 250

See a number that looks wrong?